1 |
Graham DY. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol 2014;20:5191-5204.
DOI
ScienceOn
|
2 |
Comfort MW. Gastric acidity before and after development of gastric cancer: its etiologic, diagnostic and prognostic significance. Ann Intern Med 1951;34:1331-1348.
DOI
ScienceOn
|
3 |
Graham DY, Asaka M. Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. J Gastroenterol 2010;45:1-8.
DOI
|
4 |
Cheli R, Perasso A, Giacosa A. Gastritis: A Clinical Review. Berlin: Springer-Verlag, 1987.
|
5 |
Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554-3560.
|
6 |
Shiotani A, Cen P, Graham DY. Eradication of gastric cancer is now both possible and practical. Semin Cancer Biol 2013;23(6 Pt B):492-501.
DOI
ScienceOn
|
7 |
Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1:1273-1275.
|
8 |
International Agency for Research on Cancer, ed. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 61, Schistosomes, Liver Flukes and Helicobacter pylori. Lyon: International Agency for Research on Cancer, 1994.
|
9 |
International Agency for Research on Cancer, ed. IARC Working Group Reports. Vol. 8, Helicobacter pylori Eradication as a Strategy for Preventing Gastric Cancer. Lyon: International Agency for Research on Cancer, 2014.
|
10 |
Asaka M, Kato M, Sakamoto N. Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan. J Gastroenterol 2014;49:1-8.
DOI
ScienceOn
|
11 |
Asaka M. A new approach for elimination of gastric cancer deaths in Japan. Int J Cancer 2013;132:1272-1276.
DOI
ScienceOn
|
12 |
Graham DY, Shiotani A. The time to eradicate gastric cancer is now. Gut 2005;54:735-738.
DOI
ScienceOn
|
13 |
Bracken MB. Risk, Chance, and Causation: Investigating the Origins and Treatment of Disease. New Haven: Yale University Press, 2013.
|
14 |
Hanada K, Uchida T, Tsukamoto Y, et al. Helicobacter pylori infection introduces DNA double-strand breaks in host cells. Infect Immun 2014;82:4182-4189.
DOI
ScienceOn
|
15 |
Wang C, Weber A, Graham DY. Age, period, and cohort effects on gastric cancer mortality. Dig Dis Sci 2015;60:514-523.
DOI
ScienceOn
|
16 |
Lim SH, Kwon JW, Kim N, et al. Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years. BMC Gastroenterol 2013;13:104.
DOI
ScienceOn
|
17 |
Rugge M, Correa P, Di Mario F, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis 2008;40:650-658.
DOI
ScienceOn
|
18 |
Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004;109:138-143.
DOI
ScienceOn
|
19 |
Shin DW, Cho J, Kim SH, et al. Preferences for the "screen and treat" strategy of Helicobacter pylori to prevent gastric cancer in healthy Korean populations. Helicobacter 2013;18:262-269.
DOI
ScienceOn
|
20 |
Park JM, Hahm KB. The Korean perspective of Helicobacter pylori infection: lessons from the Japanese government's policy to prevent gastric cancer. Dig Dis 2014;32:290-294.
DOI
ScienceOn
|
21 |
Chung JW, Lee GH, Han JH, et al. The trends of oneweek first-line and second-line eradication therapy for Helicobacter pylori infection in Korea. Hepatogastroenterology 2011;58:246-250.
|
22 |
Yoon JH, Baik GH, Sohn KM, et al. Trends in the eradication rates of Helicobacter pylori infection for eleven years. World J Gastroenterol 2012;18:6628-6634.
DOI
ScienceOn
|
23 |
Jung YS, Lee SH, Park CS, et al. Trends in the eradication rates of Helicobacter pylori infection in Daegu and Gyeongsangbuk-do, Korea: multicenter study over 13 years. Korean J Gastroenterol 2014;63:82-89.
DOI
ScienceOn
|
24 |
Jeon HK, Kim GH. Does standard triple therapy still have a role in first-line Helicobacter pylori eradication in Korea? J Korean Med Sci 2014;29:619-620.
DOI
ScienceOn
|
25 |
Gong EJ, Yun SC, Jung HY, et al. Meta-analysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change? J Korean Med Sci 2014;29:704-713.
DOI
ScienceOn
|
26 |
Hanada K, Graham DY. Helicobacter pylori and the molecular pathogenesis of intestinal-type gastric carcinoma. Expert Rev Anticancer Ther 2014;14:947-954.
DOI
ScienceOn
|
27 |
Graham DY, Lee YC, Wu MS. Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. Clin Gastroenterol Hepatol 2014;12:177.e3-186.e3.
DOI
ScienceOn
|
28 |
Furuta T, Graham DY. Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection. Gastroenterol Clin North Am 2010;39:465-480.
DOI
ScienceOn
|
29 |
Lee SY. Future candidates for indications of Helicobacter pylori eradication: do the indications need to be revised? J Gastroenterol Hepatol 2012;27:200-211.
DOI
ScienceOn
|
30 |
International Agency for Research on Cancer, ed. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 100B, Biologic Agents: A Review of Human Carcinogens. Lyon: International Agency for Research on Cancer, 2012:385-435.
|
31 |
Wu JY, Liou JM, Graham DY. Evidence-based recommendations for successful Helicobacter pylori treatment. Expert Rev Gastroenterol Hepatol 2014;8:21-28.
DOI
ScienceOn
|
32 |
The Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1986: estimates based on data from nine population-based cancer registries. Jpn J Clin Oncol 1991;21:318-323.
DOI
|